Action Hutchmed (china) - HCM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

221,00

Prix Achat

221,00

Prix Vente

223,00

Volume échangé

3 523

216,00 Fourchette du Jour 224,00

190,40 Plage de 52 semaines 353,00

Cap du marché

1,926B

Clôture Veille

218,00

Ouverture

216,00

Dernière Transaction

257

221

(UT)

Dernière heure de transaction

Volume financier

7 714p

VWAP

218,9745

Volume moyen (3 m)

54 353

Actions en circulation

871 601 095

Rendement du Dividende

Ratio Cours sur Bénéfices

0,00

Bénéfice par action (BPA)

Chiffre d'affairess

838M

Bénéfice net

100,78M

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.hutch-med.com

Siège social

Grand Cayman, Cym

Fondé

Hutchmed (china) Limited est coté dans le secteur Pharmaceutical Preparations de la London Stock Exchange avec le ticker HCM. Le dernier cours de clôture d'Hutchmed (china) était de 218,00p. Au cours de la dernière année, les actions de Hutchmed (china) ont été négociées dans une fourchette de prix de 190,40p à 353,00p.

Hutchmed (china) compte actuellement 871 601 095 actions en circulation. La capitalisation boursière d'Hutchmed (china) est de £1,90 milliard.

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited 28 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED") notes the below text, which is from an announcement...

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Ltd - Hong Kong-based biopharmaceutical firm - Says its lung cancer treatment Orpathys has received full approval in C ...

Hutchmed China disposes of 45% stake in Shanghai joint venture

Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd t ...

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited 02 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED") notes the below text, which is from an...

Hutchmed (China) Limited US$608m Divestment of Non-Core Joint Venture

Hutchmed (China) Limited 02 January 2025 HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture - HUTCHMED continues to deliver on its strategy outlined in November 2022 to...

Hutchmed (China) Limited Appointment of Joint Corporate Broker

Hutchmed (China) Limited 31 December 2024 Appointment of Cavendish as Joint Corporate Broker in London Hong Kong, Shanghai & Florham Park, NJ - Tuesday, December 31, 2024: HUTCHMED...

Hutchmed (China) Limited Blocklisting Six Monthly Return

Hutchmed (China) Limited 30 December 2024 Blocklisting Six Monthly Return Hong Kong, Shanghai & Florham Park, NJ - Monday, December 30, 2024: HUTCHMED (China) Limited ("HUTCHMED" or...

IN BRIEF: Hutchmed to get Takeda milestone payment

Ltd - Hong Kong-based biopharmaceutical firm - Is to receive a USD10 million milestone payment from partner Takeda Pha ...

Hutchmed China injection approval could be a "paradigm shift"

Hutchmed China Ltd on Tuesday reported it was granted conditional approval in China for an injection to treat endomet ...

Hutchmed (China) Limited Total Voting Rights

Hutchmed (China) Limited 29 November 2024 Total Voting Rights Hong Kong, Shanghai & Florham Park, NJ - Friday, November 29, 2024: HUTCHMED (China) Limited ("HUTCHMED...

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited 28 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED") notes the below text, which is from an announcement...

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Ltd - Hong Kong-based biopharmaceutical firm - Says its lung cancer treatment Orpathys has received full approval in C ...

Hutchmed China disposes of 45% stake in Shanghai joint venture

Hutchmed (China) Ltd on Thursday said it has agreed to divest a 45% stake in Shanghai Hutchison Pharmaceuticals Ltd t ...

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited 02 January 2025 Overseas Regulatory Announcement - Disposal Transaction HUTCHMED (China) Limited ("HUTCHMED") notes the below text, which is from an...

Hutchmed (China) Limited US$608m Divestment of Non-Core Joint Venture

Hutchmed (China) Limited 02 January 2025 HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture - HUTCHMED continues to deliver on its strategy outlined in November 2022 to...

Hutchmed (China) Limited Appointment of Joint Corporate Broker

Hutchmed (China) Limited 31 December 2024 Appointment of Cavendish as Joint Corporate Broker in London Hong Kong, Shanghai & Florham Park, NJ - Tuesday, December 31, 2024: HUTCHMED...

Hutchmed (China) Limited Blocklisting Six Monthly Return

Hutchmed (China) Limited 30 December 2024 Blocklisting Six Monthly Return Hong Kong, Shanghai & Florham Park, NJ - Monday, December 30, 2024: HUTCHMED (China) Limited ("HUTCHMED" or...

IN BRIEF: Hutchmed to get Takeda milestone payment

Ltd - Hong Kong-based biopharmaceutical firm - Is to receive a USD10 million milestone payment from partner Takeda Pha ...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-13	-5.55555555556	234	236	216	39613	222.67403718	DE
4	-21	-8.67768595041	242	259	216	44084	234.95649534	DE
12	-69	-23.7931034483	290	300	216	54353	254.98106472	DE
26	-69	-23.7931034483	290	336	216	101150	286.84011888	DE
52	17	8.33333333333	204	353	190.4	85001	284.89576526	DE
156	-168.5	-43.2605905006	389.5	423.5	130	96946	245.92931958	DE
260	-159	-41.8421052632	380	656	130	100767	345.936219	DE

HCM - Frequently Asked Questions (FAQ)

What is the current Hutchmed (china) share price?

The current share price of Hutchmed (china) is 221,00p

How many Hutchmed (china) shares are in issue?

Hutchmed (china) has 871 601 095 shares in issue

What is the market cap of Hutchmed (china)?

The market capitalisation of Hutchmed (china) is GBP 1,9B

What is the 1 year trading range for Hutchmed (china) share price?

Hutchmed (china) has traded in the range of 190,40p to 353,00p during the past year

What is the reporting currency for Hutchmed (china)?

Hutchmed (china) reports financial results in USD

What is the latest annual turnover for Hutchmed (china)?

The latest annual turnover of Hutchmed (china) is USD 838M

What is the latest annual profit for Hutchmed (china)?

The latest annual profit of Hutchmed (china) is USD 100,78M

What is the registered address of Hutchmed (china)?

The registered address for Hutchmed (china) is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1 1104

What is the Hutchmed (china) website address?

The website address for Hutchmed (china) is www.hutch-med.com

Which industry sector does Hutchmed (china) operate in?

Hutchmed (china) operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MACMarechale Capital Plc	3,80p (117,14%)	38,62M
DKEDukemount Capital Plc	0,045p (42,86%)	905,37M
SCGLSealand Capital Galaxy Limited	8,00p (37,93%)	13,92M
OBDOxford Biodynamics Plc	0,65p (30,00%)	5,03M
BKYBerkeley Energia Limited	19,25p (20,31%)	1,06M
NFXNuformix Plc	0,085p (-41,38%)	262,46M
PPSProton Motor Power Systems Plc	0,225p (-25,00%)	983,97k
VASTVast Resources Plc	0,115p (-19,30%)	183,07M
GSCGs Chain Plc	1,30p (-16,13%)	629k
SYMESupply@me Capital Plc	0,0026p (-16,13%)	144,24M
DKEDukemount Capital Plc	0,045p (42,86%)	905,37M
NTVONativo Resources Plc	0,0019p (0,00%)	467,88M
INSPInspirit Energy Holdings Plc	0,0029p (11,54%)	429,63M
MSMNMosman Oil And Gas Limited	0,025p (-3,85%)	401,42M
TRPTower Resources Plc	0,0285p (-3,39%)	303,27M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hutchmed (china) Limited (HCM)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Hutchmed (china) Limited

HCM Dernières nouvelles

Hutchmed (China) Limited Overseas Regulatory Announcement

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Hutchmed China disposes of 45% stake in Shanghai joint venture

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited US$608m Divestment of Non-Core Joint Venture

Hutchmed (China) Limited Appointment of Joint Corporate Broker

Hutchmed (China) Limited Blocklisting Six Monthly Return

IN BRIEF: Hutchmed to get Takeda milestone payment

Hutchmed China injection approval could be a "paradigm shift"

Hutchmed (China) Limited Total Voting Rights

Hutchmed (China) Limited Overseas Regulatory Announcement

IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China

Hutchmed China disposes of 45% stake in Shanghai joint venture

Hutchmed (China) Limited Overseas Regulatory Announcement

Hutchmed (China) Limited US$608m Divestment of Non-Core Joint Venture

Hutchmed (China) Limited Appointment of Joint Corporate Broker

Hutchmed (China) Limited Blocklisting Six Monthly Return

IN BRIEF: Hutchmed to get Takeda milestone payment

HCM - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Hutchmed (china) Limited (HCM) Cours

Hutchmed (china) Limited (HCM)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Hutchmed (china) Limited

HCM Dernières nouvelles

HCM - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités